dc.contributor.author | Bebek, Nerses | |
dc.contributor.author | Şirin, Nermin Görkem | |
dc.contributor.author | Baykan, Betül | |
dc.contributor.author | Atalar, Arife Çimen | |
dc.date.accessioned | 2021-12-10T12:03:03Z | |
dc.date.available | 2021-12-10T12:03:03Z | |
dc.identifier.citation | Atalar A. Ç. , Şirin N. G. , Bebek N., Baykan B., "Predictors of successful valproate withdrawal in women with epilepsy.", Epilepsy & behavior : E&B, cilt.119, ss.107980, 2021 | |
dc.identifier.issn | 1525-5050 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a5078a88-e7c4-444b-b4c7-6118d4ffbc56 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/173144 | |
dc.identifier.uri | https://doi.org/10.1016/j.yebeh.2021.107980 | |
dc.description.abstract | Objective: Valproate (VPA) use was restricted due to its teratogenic risks in women with epilepsy (WWE). We aimed to assess the outcome and predictors of treatment decisions of withdrawal/switch or continuation of VPA in WWE. Methods: We included 214 consecutive WWE with a follow-up time of 9.57 +/- 7.04 years, who have used (n = 142) or are still using VPA (n = 72) during their reproductive ages. The demographic, clinical, and electroencephalography (EEG) properties of WWE who could withdraw (successful withdrawal; n = 142) and could not withdraw VPA (unsuccessful withdrawal; n = 36) were compared statistically. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Psikiyatri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | DAVRANIŞ BİLİMLERİ | |
dc.title | Predictors of successful valproate withdrawal in women with epilepsy. | |
dc.type | Makale | |
dc.relation.journal | Epilepsy & behavior : E&B | |
dc.contributor.department | , , | |
dc.identifier.volume | 119 | |
dc.identifier.startpage | 107980 | |
dc.identifier.endpage | 107980 | |
dc.contributor.firstauthorID | 2622843 | |